Network Meta-Analysis To Assess The Relative Efficacy of Empagliflozin Monotherapy Over 24, 52, And 76 Weeks In Patients With Type 2 Diabetes Mellitus (T2DM)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1843
https://www.valueinhealthjournal.com/article/S1098-3015(16)33209-0/fulltext
Title :
Network Meta-Analysis To Assess The Relative Efficacy of Empagliflozin Monotherapy Over 24, 52, And 76 Weeks In Patients With Type 2 Diabetes Mellitus (T2DM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33209-0&doi=10.1016/j.jval.2016.09.1843
First page :
A667
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1742